Paraneoplastic cerebellar degeneration: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 16: | Line 16: | ||
{{CMG}} | {{CMG}} | ||
==Overview== | |||
'''Paraneoplastic cerebellar degeneration''' is a [[paraneoplastic phenomenon]] associated with [[lung]], [[ovarian]], [[breast]], and other [[cancer]]s. | '''Paraneoplastic cerebellar degeneration''' is a [[paraneoplastic phenomenon]] associated with [[lung]], [[ovarian]], [[breast]], and other [[cancer]]s. | ||
Line 31: | Line 31: | ||
[[Category:Neurology]] | [[Category:Neurology]] | ||
[[Category:Oncology]] | [[Category:Oncology]] | ||
[[Category:Oncology stub]] | |||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} |
Revision as of 19:18, 20 January 2012
Paraneoplastic cerebellar degeneration | |
ICD-10 | G13.0 |
---|---|
ICD-9 | 334.9 |
DiseasesDB | 33977 |
eMedicine | neuro/299 |
MeSH | D020362 |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Paraneoplastic cerebellar degeneration is a paraneoplastic phenomenon associated with lung, ovarian, breast, and other cancers.
It is believed to be due to an autoimmune reaction targeted against components of the central nervous system (specifically Purkinje cells and large brain stem nuclei).
It typically presents as a subacute progressive cerebellar ataxia, both truncal and appendicular.